Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2Phase NA 1

Status

Unknown 2Recruiting 2Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 4OTHER_GOV 2

Study Type

Interventional 6Observational 2

Sponsor

Cancer Type

Thoracic 43Gynecologic 9Head & Neck 7Gastrointestinal 6Other solid neoplasm 2Genitourinary 2Other hematologic neoplasm 1Dermatologic 1CNS 1

Conditions

Esophageal Neoplasms 3Stomach Neoplasms 1Esophageal Squamous Cell Carcinoma 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 325Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Platinum Compounds × Gastrointestinal × Clear all
NCT07629817 2026-06-05

HCHTOG2603

Henan Cancer Hospital

Phase 3 Not yet recruiting
1,044 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04821778 2026-01-21

Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 3 Recruiting
2,000 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT04821843 2026-01-21

Neoadjuvant Treatment Modalities in Esophageal Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 3 Recruiting
2,000 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT07334587 2026-01-12

Comparison of Efficacy and Safety Between FOLFOX-6 and CAPOX in Metastatic Colorectal Carcinoma

Allama Iqbal Medical College

Phase NA Enrolling by invitation
248 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06231680 2024-03-29

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

Henan Cancer Hospital

Phase 2 Unknown
132 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT02845986 2020-02-05

CLASS-04

Fujian Medical University

Phase 2 Unknown
251 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡